Dolby Family Ventures
San Francisco · Pre-Seed–Series A
Investment thesis
The firm backs visionary scientists and engineers working on breakthrough technologies across electronics, audio, recording, and signal processing domains. It emphasizes technical excellence and supports entrepreneurs solving society's biggest problems through early-stage capital and expertise, continuing the legacy of Ray Dolby's pioneering work in transformative technologies.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 5 of 5 portfolio companiesBiotech ×3Medical Devices ×3AI & Machine Learning ×2Deep Tech ×2Advanced Manufacturing ×1Cleantech ×1Climate Tech ×1Defense Tech ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathTwelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology. The company targets industrial applications in the chemical and energy sectors.
Advanced ManufacturingCleantechClimate TechNew MaterialsMoses Lake, US
Nicholas Flanders(Founder & CEO)inEtosha Cave(Founder)Kendra Kuhl(Founder)in
Cognitive Space develops AI-driven automation software for satellite operations, enabling constellation operators to scale while meeting operational requirements. The platform serves satellite operators and government agencies managing distributed space systems.
AI & Machine LearningDefense TechSaaSSpace TechHouston, US
Marc Bell(Co-Founder and CEO)Guy de Carufel(CEO & Founder)Dax Garner(CTO)Jeff Edwards(VP of Engineering)
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases. The company combines RNA biology expertise with machine learning to advance precision medicines.
AI & Machine LearningBiotechMedical DevicesNew York, US
Maria Pineda, PhD(CEO & Co-founder)Martin Akerman, PhD(CEO & Co-founder)
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
BiotechDeep TechHealthtechMedical Devices
MJ Antonini(Founder, CEO)Nicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)
Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells. The company targets the significant unmet need for remyelinating treatments that could repair damage caused by MS and potentially restore lost function.
BiotechDeep TechMedical Devices
Frequently asked questions
- What stage does Dolby Family Ventures invest at?
- Dolby Family Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Dolby Family Ventures focus on?
- Dolby Family Ventures focuses on Biotech, Medical Devices.
- Where is Dolby Family Ventures located?
- Dolby Family Ventures is headquartered in San Francisco, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.